Cargando…

Pharmaco‐disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries

AIMS: Heart failure with reduced ejection fraction (HFrEF) is treatable but guideline‐directed medical therapy (GDMT) may not be affordable or accessible to people living with the disease. METHODS AND RESULTS: In this cross‐sectional survey, we investigated the price, affordability, and accessibilit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Averbuch, Tauben, Esfahani, Meisam, Khatib, Rani, Kayima, James, Miranda, Juan Jaime, Wadhera, Rishi K., Zannad, Faiez, Pandey, Ambarish, Van Spall, Harriette G. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567666/ https://www.ncbi.nlm.nih.gov/pubmed/37646297 http://dx.doi.org/10.1002/ehf2.14468

Ejemplares similares

Systematic review of academic bullying in medical settings: dynamics and consequences
por: Averbuch, Tauben, et al.
Publicado: (2021)

Temporal Trends and Factors Associated With the Inclusion of Patient‐Reported Outcomes in Heart Failure Randomized Controlled Trials: A Systematic Review
por: Eliya, Yousif, et al.
Publicado: (2021)

The LENT index predicts 30 day outcomes following hospitalization for heart failure
por: Van Spall, Harriette GC, et al.
Publicado: (2020)

Applications of artificial intelligence and machine learning in heart failure
por: Averbuch, Tauben, et al.
Publicado: (2022)

Derivation and validation of a two‐variable index to predict 30‐day outcomes following heart failure hospitalization
por: Averbuch, Tauben, et al.
Publicado: (2021)

COVID-19 and Katrina: recalcitrant racial disparities
por: Van Spall, Harriette G C, et al.
Publicado: (2020)

Urban–rural disparities in diabetes-related mortality in the USA 1999–2019
por: Kobo, Ofer, et al.
Publicado: (2022)

Comparison of Medicare Advantage vs Traditional Medicare for Health Care Access, Affordability, and Use of Preventive Services Among Adults With Low Income
por: Aggarwal, Rahul, et al.
Publicado: (2022)

Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies
por: Averbuch, Tauben, et al.
Publicado: (2023)

RACIAL AND ETHNIC DISPARITIES IN DELAYING OR NOT RECEIVING MEDICAL CARE DURING THE COVID-19 PANDEMIC IN THE UNITED STATES
por: Ahmed, Ahmed, et al.
Publicado: (2022)

Racial/Ethnic Disparities in Delaying or Not Receiving Medical Care During the COVID-19 Pandemic
por: Ahmed, Ahmed, et al.
Publicado: (2022)

Pharmaco-prosthodontics revisited
por: Jagadeeshwaran, A. R., et al.
Publicado: (2012)

PHARMACO – THERAPEUTICS OF DASEMANI DRUGS
por: Sircar, N. N.
Publicado: (1984)

ArrhythmoGenoPharmacoTherapy
por: Tosaki, Arpad
Publicado: (2020)

Remote Patient Monitoring for Patients with Heart Failure: Sex- and Race-based Disparities and Opportunities
por: Mastoris, Ioannis, et al.
Publicado: (2023)

Medicare eligibility and healthcare access, affordability, and financial strain for low- and higher-income adults in the United States: A regression discontinuity analysis
por: Aggarwal, Rahul, et al.
Publicado: (2022)

From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006
por: Bajcar, Jana M, et al.
Publicado: (2010)

Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value
por: Zoons, E., et al.
Publicado: (2012)

National Trends of Gender Disparity in Canadian Cardiovascular Society Guideline Authors, 2001-2020
por: Rai, Devesh, et al.
Publicado: (2021)

Non-pharmaco, non-invasive management of coronary no-reflow phenomenon
por: Sinha, Santosh Kumar, et al.
Publicado: (2020)

Facilitated/Pharmaco-invasive Approaches in STEMI
por: Capodanno, Davide, et al.
Publicado: (2012)

Epigenetics and pharmaco-epigenetics in the primary headaches
por: Montagna, Pasquale
Publicado: (2008)

Pharmaco-Immunomodulatory Therapy in COVID-19
por: Rizk, John G., et al.
Publicado: (2020)

CHEERS to 30 Years of PharmacoEconomics
por: Milne, Richard, et al.
Publicado: (2021)

Introduction
por: Zannad, Faiez
Publicado: (2019)

Un chercheur à succès est un chercheur qui a échoué et a recommencé
por: Zannad, Faiez
Publicado: (2022)

Neuromodulation in heart failure( )
por: Zannad, Faiez
Publicado: (2022)

Racial Disparities in Obesity‐Related Cardiovascular Mortality in the United States: Temporal Trends From 1999 to 2020
por: Raisi‐Estabragh, Zahra, et al.
Publicado: (2023)

PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis
por: Feizi, Nikta, et al.
Publicado: (2021)

Pharmaco-management of inhalation injuries for burn survivors
por: Bartley, Anthony C, et al.
Publicado: (2009)

Pharmaco-genomics and anaesthesia: Mysteries, correlations and facts
por: Bhaskar, S Bala, et al.
Publicado: (2013)

Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis
por: Buysschaert, Ian, et al.
Publicado: (2008)

Quantitative Pharmaco-Electroencephalography in Antiepileptic Drug Research
por: Höller, Yvonne, et al.
Publicado: (2018)

Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
por: Vrachatis, Dimitrios A., et al.
Publicado: (2020)

Effectiveness of implementation interventions in improving physician adherence to guideline recommendations in heart failure: a systematic review
por: Shanbhag, Deepti, et al.
Publicado: (2018)

Dietary recommendations in Spain –affordability and environmental sustainability?
por: González-García, Sara, et al.
Publicado: (2020)

Transitional care quality indicators to assess quality of care following hospitalisation for chronic obstructive pulmonary disease and heart failure: a systematic review protocol
por: Michael, Faith, et al.
Publicado: (2019)

Effectiveness of implementation strategies in improving physician adherence to guideline recommendations in heart failure: a systematic review protocol
por: Van Spall, Harriette G C, et al.
Publicado: (2016)

Correction to: Quantitative Pharmaco-Electroencephalography in Antiepileptic Drug Research
por: Höller, Yvonne, et al.
Publicado: (2019)

Predictors of Pharmaco-Resistance in Patients with Post-Stroke Epilepsy
por: Lattanzi, Simona, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qusrjdn2qvgd754871fca4e6pe